hoe 33342 and Malignant Melanoma

hoe 33342 has been researched along with Malignant Melanoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chanvorachote, P; Chaotham, C; Ninsontia, C; Pongjit, K1
Burns, PN; Foster, FS; Goertz, DE; Kerbel, RS; Yu, JL1
Burch, JA; Darrow, TL; Grichnik, JM; Liu, J; Schulteis, RD; Seigler, HF; Shan, S; Vervaert, CE1
Danoy, PA; Dong, Y; Dunn, IS; Jacobs, JJ; Kaushal, A; McGregor, K; Michel, J; Sturm, RA; Wong, SS; Zhang, XM1
Rofstad, EK; Tufto, I1
Carmeliet, P; Coomber, BL; Kerbel, RS; Nagy, A; Rak, JW; Yu, JL1
Baguley, BC; Finlay, GJ1

Other Studies

7 other study(ies) available for hoe 33342 and Malignant Melanoma

ArticleYear
Silymarin selectively protects human renal cells from cisplatin-induced cell death.
    Pharmaceutical biology, 2011, Volume: 49, Issue:10

    Topics: Acute Kidney Injury; Antineoplastic Agents; Antioxidants; Apoptosis; Benzimidazoles; Cell Death; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Formazans; Humans; Kidney; Lung Neoplasms; Melanoma; Propidium; Protective Agents; Silybum marianum; Silymarin; Tetrazolium Salts; Tumor Cells, Cultured

2011
High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow.
    Cancer research, 2002, Nov-15, Volume: 62, Issue:22

    Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Humans; Melanoma; Mice; Mice, Nude; Neovascularization, Pathologic; Organophosphorus Compounds; Staining and Labeling; Tumor Cells, Cultured; Ultrasonics; Ultrasonography; Xenograft Model Antitumor Assays

2002
Melanoma, a tumor based on a mutant stem cell?
    The Journal of investigative dermatology, 2006, Volume: 126, Issue:1

    Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dendritic Cells; Fluorescent Dyes; gp100 Melanoma Antigen; Humans; Intermediate Filament Proteins; Melanoma; Membrane Glycoproteins; Mutation; Neoplasm Metastasis; Neoplasm Proteins; Neoplastic Stem Cells; Nerve Tissue Proteins; Nestin; Skin Neoplasms

2006
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
    Biochemical pharmacology, 1994, Mar-02, Volume: 47, Issue:5

    Topics: Base Sequence; Benzimidazoles; Bisbenzimidazole; Cell Cycle; Cell Differentiation; Cell Survival; Chromomycin A3; DNA-Binding Proteins; DNA, Neoplasm; HeLa Cells; Humans; Melanoma; Membrane Glycoproteins; Molecular Sequence Data; Monophenol Monooxygenase; Oxidoreductases; Promoter Regions, Genetic; Proteins; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured

1994
Transient perfusion in human melanoma xenografts.
    British journal of cancer, 1995, Volume: 71, Issue:4

    Topics: Animals; Benzimidazoles; Carbocyanines; Cell Line; Fluorescent Dyes; Humans; Melanoma; Mice; Mice, Nude; Microcirculation; Perfusion; Staining and Labeling; Transplantation, Heterologous; Tumor Cells, Cultured

1995
Heterogeneous vascular dependence of tumor cell populations.
    The American journal of pathology, 2001, Volume: 158, Issue:4

    Topics: Animals; Benzimidazoles; Blood Vessels; Cell Division; DNA-Binding Proteins; Fluorescent Dyes; Genotype; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Teratoma; Transcription Factors; Transplantation, Heterologous

2001
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5

    Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay

1990